FIQLX | FJPTX | FIQLX / FJPTX | |
Total Expense Ratio | 0.56 | 1.20 | 47% |
Annual Report Gross Expense Ratio | 0.56 | 1.20 | 47% |
Fund Existence | 7 years | 15 years | - |
Gain YTD | 12.477 | 12.116 | 103% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 763M | 763M | 100% |
Annual Yield % from dividends | 2.44 | 1.88 | 130% |
Returns for 1 year | 15.15 | 14.38 | 105% |
Returns for 3 years | 40.77 | 37.87 | 108% |
Returns for 5 years | 25.06 | 20.71 | 121% |
Returns for 10 years | N/A | 54.12 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 28.61 | 0.04 | +0.14% |
Fidelity Advisor Biotechnology Z | |||
AZNAX | 11.01 | -0.01 | -0.09% |
Virtus Income & Growth A | |||
NQGAX | 38.21 | -0.06 | -0.16% |
Nuveen Global Equity Income A | |||
MNHWX | 25.87 | -0.11 | -0.42% |
Manning & Napier Pro-Blend Max Term W | |||
LIAGX | 15.47 | -0.12 | -0.77% |
Lord Abbett International Growth I |